Results 101 to 110 of about 2,610,836 (314)

Grading and Study of Biological Markers in Ductal Carcinoma in situ and Concurrent Infiltrating Ductal Carcinoma of Breast [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: Breast cancer is the most common cancer in women. Breast cancer has surpassed cervical cancer and is now the leading cause of cancer death; however, cervical cancer still remains common in rural areas.
Lovely George, Muktha Ramesh Pai
doaj   +1 more source

Radiotherapy of Ductal Carcinoma In Situ [PDF]

Breast Care, 2015
Ductal carcinoma in situ (DCIS) is a heterogeneous disease in both its biology and clinical course. In the past, recurrence rates after breast-conserving surgery have been as high as 30% after 10 years. The introduction of mammography screening and advances in imaging have led to an increase in the detection of DCIS.
David Krug, Rainer Souchon
openaire   +3 more sources

Association of the 12-Gene Breast DCIS Score® Assay With Local Recurrence in Patients With Ductal Carcinoma In Situ Treated on Accelerated Partial Breast Radiotherapy Protocols

Frontiers in Oncology, 2020
Background The following analysis explores clinicopathologic factors and the 12-gene Breast DCIS Score test result in order to better define an appropriate DCIS (ductal carcinoma in situ) population eligible for APBI (accelerated partial breast ...
C. Leonard, Shannon Tole, M. Turner, J. Bennett, K. Howell, D. Carter   +5 more
semanticscholar   +1 more source

Ductal Carcinoma in situ of the female Breast [PDF]

, 2007
The breast is the most common site of cancer in females in many parts of the world. Mammary carcinoma is either ductal arising from ducts or lobular arising from lobules.
Elkhatim, Mukhtar, Mohamed, Elgaili, Mohammadani, A.A.   +2 more
core   +1 more source

Atypical Ductal Hyperplasia at the Margin of Lumpectomy Performed for Early Stage Breast Cancer: Is there Enough Evidence to Formulate Guidelines? [PDF]

, 2012
Background. Negative margins are associated with a reduced risk of ipsilateral breast tumor recurrence (IBTR) in women with early stage breast cancer treated with breast conserving surgery (BCS).
Baker, Jennifer L, Blair, Sarah L, Hasteh, Farnaz   +2 more
core   +3 more sources

Extracellular Vesicular Delta‐Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis

Advanced Science, EarlyView.
Small cell lung cancer (SCLC) harbors high molecular heterogeneity. Using a new liquid biopsy assay, SCLC subtypes can be identified by measuring mRNA of subtype transcription factors (ASCL1, POU2F3, and NEUROD1) in exosome‐rich extracellular vesicles. Combining with Delta‐like ligand 3 (DLL3) mRNA in exosomes and its membrane protein in extracellular ...
Hong Li, Chi‐Ling Chiang, Kwang Joo Kwak, Hsin‐Lun Lee, Xinyu Wang, Giulia Romano, Michela Saviana, Robin Toft, Tai‐Shan Cheng, Yuehshih Chang, Bi‐Da Hsiang, Guan‐Wan Liu, Xiaokui Mo, Yifan Ma, Junjie Pan, Xilal Y. Rima, Truc Nguyen Kim, Eduardo Reategui, Chia‐Ning Shen, Yeh‐Shiu Chu, Carlo Croce, Peter Mu‐Hsin Chang, Yi‐Chen Yeh, David P. Carbone, Chi‐Ying F. Huang, Chi‐Lu Chiang, Patrick Nana‐Sinkam, L. James Lee   +27 more
wiley   +1 more source

Multi-Level Batch Normalization In Deep Networks For Invasive Ductal Carcinoma Cell Discrimination In Histopathology Images [PDF]

, 2019
Breast cancer is the most diagnosed cancer and the most predominant cause of death in women worldwide. Imaging techniques such as the breast cancer pathology helps in the diagnosis and monitoring of the disease. However identification of malignant cells can be challenging given the high heterogeneity in tissue absorbotion from staining agents.
arxiv   +1 more source

A novel therapy for breast cancer: implications for treatment access [PDF]

, 2019
In 2016, there were 250,000 new cases of invasive cancer and 60,000 of ductal carcinoma in situ. Mammograms are used to screen for cases of disease, but the literature shows that mammograms are highly dependent on patient characteristics and do not ...
Cespedes-Gomez, Omar
core  

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast [PDF]

Up to 50% of recurrences of ductal carcinoma in situ of the breast are associated with invasive carcinoma but no pathological or molecular features have yet been found to predict for the development of invasive disease.
A Recht, A Sales, AHS Lee, AHS Lee, AJ Guidi, B S Shoker, C Holcombe, C Jarvis, DV Parums, E Horak, ER Fryberg, HC Lichtenbeld, J P Sloane, JM Guinebretiere, K Engels, K Engels, L Martin, L Martin, M Toi, MA Gimbrone Jr, MJ Silverstein, N B Teo, N Weidner, N Weidner, PB Vermeulen, PB Vermeulen, R Valtola, S Badve, S Bosari, SC Heffelfinger, SS Brem, T Nemoto, WHC Burgdorf   +32 more
core   +2 more sources

Ductal carcinoma in situ (DCIS) [PDF]

, 2013
Part 1 of this article may be found through this link: https://www.um.edu.mt/library/oar//handle/123456789/13825DCIS is rarely seen in US, where it may appear as a microlobulated mass with mild hypoechogenicity, ductal extension, and normal acoustic ...
Vassallo, Pierre
core   +1 more source